{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:54:50Z","timestamp":1791147290536,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1833,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/mt.2011.156","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T15:17:32Z","timestamp":1312298252000},"page":"1887-1895","source":"Crossref","is-referenced-by-count":14,"title":["Alternative for Anti-TNF Antibodies for Arthritis Treatment"],"prefix":"10.1016","volume":"19","author":[{"given":"Joseph","family":"Paquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Henrionnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Pinzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Vincourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Netter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chary-Valckenaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Loeuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pourel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Grossin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.156_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.berh.2008.01.003","article-title":"Immune-mediated pathways in chronic inflammatory arthritis","volume":"22","author":"Gorman","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1038\/mt.2011.156_bib2","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/ar2358","article-title":"Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study","volume":"10","author":"Andreas","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/mt.2011.156_bib3","first-page":"291","article-title":"[The role of interleukin-6 in rheumatoid arthritis]","volume":"99","author":"Manfredi","year":"2008","journal-title":"Recenti Prog Med"},{"key":"10.1038\/mt.2011.156_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2011.156_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.autrev.2005.10.013","article-title":"The role of cytokine mRNA stability in the pathogenesis of autoimmune disease","volume":"5","author":"Seko","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1038\/mt.2011.156_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbagen.2007.09.015","article-title":"Inhibition of tumor necrosis factor \u03b1 secretion in rat Kupffer cells by siRNA: in vivo efficacy of siRNA-liposomes","volume":"1780","author":"Jing","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2011.156_bib7","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/art.20975","article-title":"Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis","volume":"52","author":"Schiffelers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2011.156_bib8","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.23660","article-title":"Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes","volume":"58","author":"Khoury","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2011.156_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.berh.2003.09.010","article-title":"The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis","volume":"18","author":"Feldmann","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1038\/mt.2011.156_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2177\/jsci.31.104","article-title":"[Pathogenic analysis of chronic inflammatory disease based on the clinical results by IL-6 blocking therapy]","volume":"31","author":"Yoshizaki","year":"2008","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1038\/mt.2011.156_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.24106","article-title":"Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis","volume":"59","author":"Bejarano","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2011.156_bib12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/ard.2008.091264","article-title":"Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study","volume":"68","author":"Hoff","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/mt.2011.156_bib13","first-page":"164","article-title":"The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitors","volume":"109","author":"Rybar","year":"2008","journal-title":"Bratisl Lek Listy"},{"key":"10.1038\/mt.2011.156_bib14","first-page":"543","article-title":"Oligonucleotides: a new resource in rheumatology","volume":"65","author":"Chary-Valckenaere","year":"1998","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1038\/mt.2011.156_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature02872","article-title":"Revealing the world of RNA interference","volume":"431","author":"Mello","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2011.156_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.gt.3302324","article-title":"Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference","volume":"11","author":"Caplen","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.156_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bcp.2004.11.011","article-title":"Inhibition of tumor necrosis factor \u03b1 secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides","volume":"69","author":"Ponnappa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/mt.2011.156_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"S\u00f8rensen","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2011.156_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbrc.2005.08.198","article-title":"Electro-transfer of small interfering RNA ameliorated arthritis in rats","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2011.156_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.bi.36.070167.002203","article-title":"The physical and chemical properties of nucleic acids","volume":"36","author":"Felsenfeld","year":"1967","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/mt.2011.156_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1015985728434","article-title":"Oligonucleotide analogues as potential chemotherapeutic agents","volume":"5","author":"Zon","year":"1988","journal-title":"Pharm Res"},{"key":"10.1038\/mt.2011.156_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-4781(90)90031-V","article-title":"Specific regulation of gene expression by antisense, sense and antigene nucleic acids","volume":"1049","author":"H\u00e9l\u00e8ne","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2011.156_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mc.20261","article-title":"High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes","volume":"46","author":"Wu","year":"2007","journal-title":"Mol Carcinog"},{"key":"10.1038\/mt.2011.156_bib24","first-page":"670","article-title":"Gene targeted agents: new opportunities for rational drug development","volume":"2","author":"Winters","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2011.156_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biochi.2009.12.012","article-title":"Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells","volume":"92","author":"Jain","year":"2010","journal-title":"Biochimie"},{"key":"10.1038\/mt.2011.156_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V90.1.331","article-title":"Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides","volume":"90","author":"Vaerman","year":"1997","journal-title":"Blood"},{"key":"10.1038\/mt.2011.156_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-022X(86)90021-7","article-title":"Oligodeoxynucleotide stability in subcellular extracts and culture media","volume":"13","author":"Wickstrom","year":"1986","journal-title":"J Biochem Biophys Methods"},{"key":"10.1038\/mt.2011.156_bib28","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/0024-3205(91)90480-Y","article-title":"Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera","volume":"49","author":"Akhtar","year":"1991","journal-title":"Life Sci"},{"key":"10.1038\/mt.2011.156_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/ard.1994.4.67","article-title":"Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides","volume":"4","author":"Stein","year":"1994","journal-title":"Antisense Res Dev"},{"key":"10.1038\/mt.2011.156_bib30","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1021\/bi00510a024","article-title":"Biochemical and biological effects of nonionic nucleic acid methylphosphonates","volume":"20","author":"Miller","year":"1981","journal-title":"Biochemistry"},{"key":"10.1038\/mt.2011.156_bib31","first-page":"1204","article-title":"Anti-cytokine antibodies for rheumatic diseases","volume":"10","author":"Atzeni","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1038\/mt.2011.156_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.joca.2004.02.011","article-title":"Osteoarthritis of the knee\u2013clinical assessments and inflammatory markers","volume":"12","author":"Brenner","year":"2004","journal-title":"Osteoarthr Cartil"},{"key":"10.1038\/mt.2011.156_bib33","doi-asserted-by":"crossref","first-page":"12277","DOI":"10.1021\/bi801087g","article-title":"Triplex formation on DNA targets: how to choose the oligonucleotide","volume":"47","author":"Vekhoff","year":"2008","journal-title":"Biochemistry"},{"key":"10.1038\/mt.2011.156_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0020-711X(94)90203-8","article-title":"Constitutive expression of TNF-\u03b1 and -beta genes in mouse embryo: roles of cytokines as regulator and effector on development","volume":"26","author":"Kohchi","year":"1994","journal-title":"Int J Biochem"},{"key":"10.1038\/mt.2011.156_bib35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ncprheum0885","article-title":"MicroRNAs, the immune system and rheumatic disease","volume":"4","author":"Tili","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1038\/mt.2011.156_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cyto.2008.07.016","article-title":"MicroRNAs in the immune response","volume":"43","author":"Pedersen","year":"2008","journal-title":"Cytokine"},{"key":"10.1038\/mt.2011.156_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ni.1699","article-title":"The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules","volume":"10","author":"Hao","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1038\/mt.2011.156_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2011.156_bib39","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/art.24767","article-title":"Tumor necrosis factor \u03b1 and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis","volume":"60","author":"Schett","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2011.156_bib40","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.23608","article-title":"Antinociceptive effects of tumor necrosis factor \u03b1 neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target","volume":"58","author":"Boettger","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2011.156_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1038\/mt.2011.156_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.joca.2009.07.012","article-title":"Mechanical load inhibits IL-1 induced matrix degradation in articular cartilage","volume":"18","author":"Torzilli","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"10.1038\/mt.2011.156_bib43","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.24899","article-title":"Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab","volume":"61","author":"Tanaka","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1038\/mt.2011.156_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/oli.2006.16.158","article-title":"Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model","volume":"16","author":"Toub","year":"2006","journal-title":"Oligonucleotides"},{"key":"10.1038\/mt.2011.156_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.biopha.2006.07.093","article-title":"Innovative nanotechnologies for the delivery of oligonucleotides and siRNA","volume":"60","author":"Toub","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1038\/mt.2011.156_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000230752","article-title":"Arthritogenicity of unaltered and acetylated cell walls of mycobacteria","volume":"36","author":"Bonhomme","year":"1969","journal-title":"Int Arch Allergy Appl Immunol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616327812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616327812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T23:32:51Z","timestamp":1592782371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616327812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1525001616327812"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.156","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}